Global marketer a2 Milk’s recovery ran out of puff after falling 18c or 2.93 per cent to $5.97, impacted by a competitor’s comments in China. Feihe, China’s largest infant formula maker, said sales would drop sharply in the next one to two years since many women cannot bear children within six months of coronavirus vaccination – and thus delaying births. (there is no name or specific citation on who specifically said this)
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.
View more posts
One thought on “China’s Largest Infant Formula Company Rep. Says Sales Will Drop Sharply Over Next Two Years…Vaccine Prevents Many Women from Having Children for 6 Months”
Yes there is mate.